We're pleased to share that one of ICOSEP's patient organization partners,
@AfadocOnlus , will be presenting a poster, "Redefining ISS: Patient Led Insights Driving Transformative System Change in Idiopathic Short Stature," at the 13th European Conference on Rare Diseases and Orphan Products (ECRD), taking place in Prague from June 3rd - 4th, 2026.
This work highlights the work of our Redefining ISS team, showing how patient and caregiver experiences can help drive meaningful improvements in recognition, diagnosis, family decision-making, and psychosocial support for children living with Idiopathic Short Stature (ISS).
We look forward to sharing these findings with the global endocrine community and continuing conversations about improving care and outcomes for families affected by ISS.
The Redefining ISS: Improving Confidence and Clarity initiative was developed in collaboration with and funded by Novo Nordisk, while the resulting recommendations reflect the views of ICOSEP and participating patient organizations.
To learn more, please click on this link:
icosep.org/redefiningissimpr…...
Thank you!